Addiction in America: The New War on Drugs
On Dec. 5, 2018, at The Washington Post, U.S. Surgeon General Dr. Jerome Adams, health policy experts and medical professionals gather for a series of discussions about the opioid crisis, a drug epidemic that continues to rip the fabric of our nation apart. Speakers will discuss new proposals aimed at combating the crisis, address disparities in access to treatment and examine the impact of drugs on communities across the country.
Agenda
Tackling the Opioid Crisis: The Federal View
The nation’s top doctor discusses the latest proposals from the federal government aimed at combating the worst addiction epidemic in American history through prevention, intervention and treatment.
U.S. Surgeon General Jerome Adams discusses the latest proposals from the federal government aimed at combating the worst addiction epidemic in American history through prevention, intervention and treatment.
  • Dec 7, 2018
At a Washington Post Live event highlighting the national opioid epidemic, U.S. Surgeon General Jerome Adams shared a personal story about his younger brother who is currently incarcerated and struggling with addiction.
  • Dec 7, 2018
At a Washington Post Live event on addiction in America, U.S. Surgeon General Jerome Adams discussed the deadly substance fentanyl which was responsible for thousands of overdoses this year and what the federal government is doing to restrict access to it.
  • Dec 7, 2018
At a Washington Post Live event, U.S. Surgeon General Jerome Adams said that federal laws criminalizing marijuana use should be ‘looked at’ from a prison-sentencing standpoint, but cautioned that ‘marijuana primes the brain for further addiction.’
  • Dec 7, 2018
U.S. Surgeon General Jerome Adams commended the Trump Administration for taking action toward combating the national opioid epidemic at an addiction event hosted by the Washington Post.
  • Dec 7, 2018
At a Washington Post Live event, U.S. Surgeon General Jerome Adams talked about ways in which federal dollars are being used to combat opioid crisis.
  • Dec 7, 2018
Jerome Adams, MD
U.S. Surgeon General
Dr. Jerome Adams is the 20th Surgeon General of the United States. His mission as the “Nation’s Doctor,” is to advance the health of the American people. Dr. Adams’ motto as Surgeon General is “better health through better partnerships.” He is committed to strengthening relationships with all members of the health community, and forging new partnerships with members from the business, faith, education and public safety and national security communities.
Moderated by Lenny Bernstein
Health and Medicine Reporter
The Washington Post
On The Front Lines: Addiction in our Communities
A look at the impact of the opioid crisis on communities, large and small, in the United States and the toll the epidemic has taken on individuals and families. Speakers offer perspectives on access to treatment, racial and economic disparities, addiction programs for prison populations and promising new prevention models.
A look at the impact of the opioid crisis on communities, large and small, in the United States and the toll the epidemic has taken on individuals and families. Speakers offer perspectives on access to treatment, racial and economic disparities, addiction programs for prison populations and promising new prevention models.
  • Dec 7, 2018
At a Washington Post addiction event, former White House drug policy official Regina LaBelle discussed ways in which federal funds can be effectively allocated to states and local communities to help combat the national opioid crisis
  • Dec 7, 2018
At a Washington Post Live event, Newtown, Ohio Police Chief Tom Synan talked about how law enforcement officers should approach dealing with opioid crises in their communities: ‘I’ve stood over the bodies of people that have over-dosed...It is time that we stop viewing addiction as a crime,’ he said.
  • Dec 7, 2018
At a Washington Post Live event, District of Columbia Chief Medical Examiner Dr. Roger Mitchell, talked about how the district is working to curb the opioid epidemic in the city, and how many of those affected in DC are older, black men.
  • Dec 7, 2018
Traci C. Green, PhD
Deputy Director, Injury Prevention Research Center, Boston Medical Center
Dr. Green is an epidemiologist whose research focuses on drug use, opioid addiction, and drug-related injury. Currently, she is Deputy Director of the Boston Medical Center Injury Prevention Center, Associate Professor of Emergency Medicine and Community Health Sciences at Boston University, and Adjunct Associate Professor at Brown University where she co-directs the Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose at Rhode Island Hospital.
Regina M. LaBelle
Director, Addiction and Public Policy Initiative at Georgetown University's O'Neill Institute; Former Chief of Staff, White House Office of National Drug Control Policy (2009-2017)
Regina LaBelle is the former Chief of Staff in the White House Office of National Drug Control Policy. In that role, she was charged with overseeing day to day operations at ONDCP. She also assisted the director of National Drug Control Policy in implementing the Administration’s National Drug Control Strategy.
Roger A. Mitchell
Chief Medical Examiner, District of Columbia
Dr. Roger Mitchell Jr. is board certified in Anatomic and Forensic Pathology by the American Board of Pathology and a Fellow with the National Association of Medical Examiners. Dr. Mitchell sits on national subcommittees for NAME including Education & Planning, Strategic Planning, and is the Immediate Past Chair for the Deaths in Custody Subcommittee. Dr. Mitchell has recently served as the National Co-Chair for the National Medical Associations (NMA) Working Group on Gun Violence and Police Use of Force.
Tom Synan
Chief of Police, Newtown, Ohio
Tom Synan is Chief of Police in Newtown, Ohio. Synan is a United States Marine Corps veteran and a 25-year police veteran with the Newtown Police Department. For the last 10 years as Police Chief and as is a SWAT Team Leader veteran.
Moderated by Katie Zezima
National Reporter
The Washington Post
What’s Next: Examining New Approaches to Harm Reduction
A spotlight on treatment models aimed at minimizing the harmful effects of drug use, including controversial “safe-injection sites” in select cities across the country.
A spotlight on treatment models aimed at minimizing the harmful effects of drug use, including controversial “safe-injection sites” in select cities across the country.
  • Dec 7, 2018
At a Washington Post Live event, drug and addiction experts weighed in on whether illegal safe-injection sites will eventually open in select U.S. cities as a harm-reduction approach to combat the opioid crisis.
  • Dec 7, 2018
Alex H. Kral, PhD
Distinguished Fellow, RTI International
Alex H. Kral is an infectious disease epidemiologist with expertise in community-based research with urban poor populations. His policy and evaluation research has included syringe exchange programs, overdose education and naloxone distribution programs, and supervised consumption service programs.  
David W. Murray, PhD
Senior Fellow, Hudson Institute
David W. Murray is a Senior Fellow at Hudson Institute where he co-directs the Center for Substance Abuse Policy Research. While serving previous posts as Chief Scientist and Associate Deputy Director (Supply Reduction) in the federal government’s Office of National Drug Control Policy, Murray directed extensive scientific research on all aspects of the drug problem and helped coordinate high-level inter-agency efforts to limit the production of illicit drugs and counter the transnational criminal organizations that control their global shipment and marketing.
Moderated by Lenny Bernstein
Health and Medicine Reporter
The Washington Post
Sponsor Speaker
SAS U.S. Government Medical Director Steve Kearney delivered opening remarks at a Washington Post event on the opioid crisis in America.
  • Dec 7, 2018
Steve Kearney, PharmD
Medical Director, U.S. Government, SAS
Steve Kearney works to solve today’s most complex state, local and federal health care challenges with advanced analytics. Under his leadership, he advises how data-based decisions can drive good policy and empower change. Prior to SAS, he was Director of the Medical Outcomes Specialists group for Pfizer Global Medical. Kearney developed measures and systematic implementations for improved health outcomes.
About Washington Post Live
Washington Post Live is the newsroom’s live journalism platform. Top-level government and business leaders, emerging voices and newsmakers discuss the most pressing national and global issues of the day.